
Biotechnology/Pharmaceuticals
Managed IT Services for Biotechs for Always-On Work
In biotechnology and pharmaceutical organizations, meaningful work happens daily across discovery, development, and production. Hyopsys stands behind the technology that supports this work, providing a steady foundation so systems remain on, coordinated, and ready as science advances and operations grow.
Let’s Keep Scientific Work Supported,
Day After Day
Research, clinical programs, and regulated operations move forward every day. Hyopsys works with biotechnology and pharmaceutical teams to understand how systems support research data, production schedules, and quality requirements today, and how they need to remain steady as work evolves.
Fill out the form to connect with Hyopsys. We take time to review how technology supports your labs, facilities, and business operations and help ensure the foundation beneath that work stays consistent, secure, and always available.
Frequently Asked Questions About Biotech and Pharma IT
Biotech and pharma organizations have specific questions about how Hyopsys supports their regulated technology environments. Here are answers to the questions we hear most.
21 CFR Part 11 requires electronic records to be trustworthy, unalterable, and audit-ready, which places specific demands on how systems are configured, accessed, and logged. Hyopsys implements the access controls, audit trail functionality, and validation documentation those requirements call for. When systems are updated or new platforms are introduced, compliance posture is maintained through the change.
Strong access restrictions, encrypted storage, and monitoring for unusual data movement are the core controls for protecting research data. Hyopsys also applies insider threat controls, which are especially important in research environments where departing staff may attempt to take materials. Layered protections address both external and internal risk simultaneously.
Yes. Hyopsys operates within GxP change control requirements, ensuring that updates, patches, and configuration changes go through the appropriate review and approval steps before implementation. Proper documentation throughout that process supports the quality management system and audit readiness. Changes are not pushed through without the required sign-off.
Lab instruments connected to a network introduce cybersecurity risk even when running proprietary vendor software that cannot be easily updated. Hyopsys documents each device, applies network segmentation to limit exposure, and monitors for unusual behavior. Vendor-managed equipment is included in the overall security posture, not excluded from it.
Hyopsys builds redundancy and monitoring into critical clinical systems so availability issues are caught and addressed before they become interruptions. Data integrity controls are configured so records remain timestamped, accurate, and audit-ready at all times. Unplanned downtime in a clinical environment is treated as a priority regardless of when it occurs.
M&A activity in pharma often means integrating systems across organizations with different platforms, security postures, and compliance environments. Hyopsys supports due diligence assessments and manages technical integration planning to identify conflicts before they affect operations or create compliance gaps. Integration proceeds at a pace that keeps both parties informed and operations stable.
Active trial data requires backup frequency calibrated to how often data is generated and how much loss the organization could tolerate without affecting trial validity. Recovery procedures are tested regularly so restoration is fast and data comes back intact when needed. The regulatory consequences of data loss in this environment make standard daily backup schedules insufficient on their own.
Contact Hyopsys at 267-332-6900, email info@hyopsys.com, or submit an inquiry at hyopsys.com. The conversation starts with your regulatory environment, your current IT setup, and the compliance and operational requirements your technology needs to support. Hyopsys builds a plan from there.